Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.

Abstract:

:In adults, the haemolytic-uraemic syndrome (HUS) is associated with probable causative factors in the minority of all cases. Cytotoxic drugs are one of these potential causative agents. Although metastatic cancer by itself is a recognized risk-factor for the development of HUS, therapy with mitomycin-C, with cis-platinum, and with bleomycin carries a significant, albeit extremely small, risk for the development of HUS, compared with all other cytotoxic drugs. Gemcitabine is a novel cytotoxic drug with promising activity against pancreatic adenocarcinoma. We are reporting on one patient with metastatic duodenal papillary carcinoma developing HUS while on weekly gemcitabine therapy. The presenting features in this patient were non-cardiac pulmonary oedema, renal failure, thrombocytopenia and haemolytic anaemia. The diagnosis of HUS was made on the day of admission of the patient to this institution. Upon aggressive therapy, including one single haemodialysis and five plasmaphereses, the patient recovered uneventfully, with modestly elevated creatinine-values as a remnant of the acute illness. Re-exposure to gemcitabine 6 months after the episode of HUS instituted for progressive carcinoma, thus far has not caused another episode of HUS.

journal_name

Br J Cancer

authors

Serke S,Riess H,Oettle H,Huhn D

doi

10.1038/sj.bjc.6690242

subject

Has Abstract

pub_date

1999-03-01 00:00:00

pages

1519-21

issue

9-10

eissn

0007-0920

issn

1532-1827

journal_volume

79

pub_type

杂志文章
  • A trial of chemotherapy in patients with osteosarcoma (a report to the Medical Research Council by their Working Party on Bone Sarcoma.

    abstract::Two hundred and thirty five patients with osteosarcoma, aged less than 40 years, and treated by amputation or radiotherapy, were entered in a randomised trial of two forms of adjuvant chemotherapy. A two drug regimen, namely vincristine 2 mg m-2 (maximum 2mg) followed by methotrexate 200 mgm-2, given every three weeks...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1038/bjc.1986.81

    authors:

    更新日期:1986-04-01 00:00:00

  • Results from a seven-year programme of breast self-examination in 89,010 women.

    abstract::This report presents the results of a study into the effect of breast self-examination (BSE) in a large defined population within the City of Nottingham since 1979. We have examined the effect of breast self-examination in a group of patients invited to attend for education in BSE compared with a group of historical c...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1989.294

    authors: Locker AP,Caseldine J,Mitchell AK,Blamey RW,Roebuck EJ,Elston CW

    更新日期:1989-09-01 00:00:00

  • Temozolomide as salvage treatment in primary brain lymphomas.

    abstract::Methotrexate (MTX)-based chemotherapy extends survival in patients with primary brain lymphomas, but it is not clear whether multiagent chemotherapy is superior to MTX alone. Treatment options for patients with recurrent primary brain lymphoma are limited; there is no standard second-line chemotherapy. New chemotherap...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6603660

    authors: Reni M,Zaja F,Mason W,Perry J,Mazza E,Spina M,Bordonaro R,Ilariucci F,Faedi M,Corazzelli G,Manno P,Franceschi E,Pace A,Candela M,Abbadessa A,Stelitano C,Latte G,Ferreri AJ

    更新日期:2007-03-26 00:00:00

  • Platelets enhance malignant behaviours of gastric cancer cells via direct contacts.

    abstract::In this study, we aimed to analyse human cancer cell-platelet interactions in functional cell analyses and explore the molecular mechanisms behind tumour progression. Various functional analyses of gastric cancer (GC) cells were performed after direct/indirect co-incubation with platelets derived from GC patients. Fur...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-020-01134-7

    authors: Saito R,Shoda K,Maruyama S,Yamamoto A,Takiguchi K,Furuya S,Hosomura N,Akaike H,Kawaguchi Y,Amemiya H,Kawaida H,Sudo M,Inoue S,Kono H,Suzuki-Inoue K,Ichikawa D

    更新日期:2020-10-28 00:00:00

  • Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.

    abstract:BACKGROUND:Overexpression of plasma membrane multi-drug resistance protein 1 (MRP-1) can lead to multidrug resistance. In this study, we describe for the first time the expression of mitochondrial MRP-1 in untreated human normal and cancer cells and tissues. METHODS:MRP-1 expression and subcellular localisation in nor...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.40

    authors: Roundhill EA,Burchill SA

    更新日期:2012-03-13 00:00:00

  • Expression of NRG1 and its receptors in human bladder cancer.

    abstract:BACKGROUND:Therapies targeting ERBB2 have shown success in the clinic. However, response is not determined solely by expression of ERBB2. Levels of ERBB3, its preferred heterodimerisation partner and ERBB ligands may also have a role. METHODS:We measured NRG1 expression by real-time quantitative RT-PCR and ERBB recept...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.39

    authors: Forster JA,Paul AB,Harnden P,Knowles MA

    更新日期:2011-03-29 00:00:00

  • Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.

    abstract:BACKGROUND:Melatonin reduces the development of breast cancer interfering with oestrogen-signalling pathways, and also inhibits aromatase activity and expression. Our objective was to study the promoters through which melatonin modifies aromatase expression, evaluate the ability of melatonin to regulate cyclooxygenases...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605336

    authors: Martínez-Campa C,González A,Mediavilla MD,Alonso-González C,Alvarez-García V,Sánchez-Barceló EJ,Cos S

    更新日期:2009-11-03 00:00:00

  • Haematological toxicity of carboplatin in rats.

    abstract::In rats a maximal tolerated dose of carboplatin (60 mg kg-1, i.v.) caused severe anaemia, leucopenia and thrombocytopenia. These indices of haematological toxicity were also observed with a maximal tolerated dose of cis-platin (6.5 mg kg-1, i.v.), but reductions in blood cell counts were less than those observed with ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1987.75

    authors: Siddik ZH,Boxall FE,Harrap KR

    更新日期:1987-04-01 00:00:00

  • Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).

    abstract::The objective of the study was to evaluate the effect of neoadjuvant chemotherapy on the survival of patients with oropharyngeal cancer. Patients with a squamous cell carcinoma of the oropharynx for whom curative radiotherapy or surgery was considered feasible were entered in a multicentric randomized trial comparing ...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1054/bjoc.2000.1512

    authors: Domenge C,Hill C,Lefebvre JL,De Raucourt D,Rhein B,Wibault P,Marandas P,Coche-Dequeant B,Stromboni-Luboinski M,Sancho-Garnier H,Luboinski B,French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).

    更新日期:2000-12-01 00:00:00

  • High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours.

    abstract::The tolerability, anti-tumour activity and pharmacokinetic interaction of high-dose intravenous cyclosporin combined with intravenous etoposide was evaluated in children. Eighteen patients with recurrent or refractory tumours, all of whom had previously received etoposide, were treated with a combination of high-dose ...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/bjc.1998.383

    authors: Bisogno G,Cowie F,Boddy A,Thomas HD,Dick G,Pinkerton CR

    更新日期:1998-06-01 00:00:00

  • DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

    abstract::DT-diaphorase (DTD) is an important enzyme for the bioreductive activation of the new alkylating indoloquinone EO9. In preclinical studies, EO9 has shown selective anti-tumour activity against solid tumours and under hypoxic conditions. The levels of three reductive enzymes have been determined in three types of human...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1995.433

    authors: Smitskamp-Wilms E,Giaccone G,Pinedo HM,van der Laan BF,Peters GJ

    更新日期:1995-10-01 00:00:00

  • Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays.

    abstract::Melanoma is one of the most aggressive types of cancer and resection of the tumour prior to dissemination of tumour cells is still the most effective treatment. Therefore, early diagnosis of melanocytic lesions is important and identification of novel (molecular) markers would be helpful to improve diagnosis. Moreover...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602612

    authors: de Wit NJ,Rijntjes J,Diepstra JH,van Kuppevelt TH,Weidle UH,Ruiter DJ,van Muijen GN

    更新日期:2005-06-20 00:00:00

  • Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study.

    abstract:BACKGROUND:Lynch syndrome (LS) is associated with a significant lifetime risk of endometrial cancer (EC). There are limited data on factors modifying the EC risk in LS patients. METHODS:The study cohort included 136 LS mutation-positive women. Exposure data were collected by postal questionnaires. Cox regression model...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2016.193

    authors: Staff S,Aaltonen M,Huhtala H,Pylvänäinen K,Mecklin JP,Mäenpää J

    更新日期:2016-07-26 00:00:00

  • Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.

    abstract::Fluorescence polarization measurement during the progress of fluorochromasia has been used to study the response of human lymphocytes to phytohaemagglutinin (PHA) and to tumour-associated antigens, as a basis for the detection of malignant disease. Polarization (P) values of both stimulated and unstimulated lymphocyte...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.9

    authors: Balding P,Light PA,Preece AW

    更新日期:1980-01-01 00:00:00

  • Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.

    abstract:BACKGROUND:Multiple myeloma is a plasma cell disorder that is characterised by clonal proliferation of malignant plasma cells in the bone marrow, monoclonal paraprotein in the blood or urine and associated organ dysfunction. It accounts for approximately 1% of cancers and 13% of haematological cancers. Myeloma arises f...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.525

    authors: Jones CI,Zabolotskaya MV,King AJ,Stewart HJ,Horne GA,Chevassut TJ,Newbury SF

    更新日期:2012-12-04 00:00:00

  • Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors.

    abstract::Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in col...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2001.1936

    authors: Shaheen RM,Ahmad SA,Liu W,Reinmuth N,Jung YD,Tseng WW,Drazan KE,Bucana CD,Hicklin DJ,Ellis LM

    更新日期:2001-08-17 00:00:00

  • Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.

    abstract:BACKGROUND:The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts. By using publicly available genomic data, ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-019-0636-x

    authors: Nicoud MB,Sterle HA,Massari NA,Táquez Delgado MA,Formoso K,Herrero Ducloux MV,Martinel Lamas D,Cremaschi GA,Medina VA

    更新日期:2020-02-01 00:00:00

  • A study of the dose response of mouse skin to cigarette smoke condensate.

    abstract::Smoke condensate from two types of cigarette, dissolved in two solvents, has been applied regularly to the backs of mice at each of seven different dose levels. Treatment was continued 3 times weekly for up to 110 weeks, by which time 509 of the 1428 treated mice had developed skin tumours. The dependence of tumour in...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1974.126

    authors: Davies RF,Lee PN,Rothwell K

    更新日期:1974-08-01 00:00:00

  • Screening and the costs of treating colorectal cancer.

    abstract::The objective of this paper is to compare the hospital costs of treating patients with colorectal cancers detected as a result of a faecal occult blood screening programme with those of patients whose cancers present symptomatically (control group). Patient-specific cost estimates are made, using case records and hosp...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1993.462

    authors: Whynes DK,Walker AR,Chamberlain JO,Hardcastle JD

    更新日期:1993-11-01 00:00:00

  • ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases.

    abstract::The activity of ZD 1839 on brain metastases (BM) from Non-Small-Cell Lung Cancer (NSCLC) is unknown. We report four cases of BM responding to ZD 1839 theraphy. ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6601116

    authors: Cappuzzo F,Calandri C,Bartolini S,Crinò L

    更新日期:2003-07-21 00:00:00

  • How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.

    abstract::The trimodality approach represented by concurrent chemoradiotherapy followed by surgical resection is a highly effective, but potentially toxic therapy for locally advanced non-small-cell lung cancer (NSCLC). In this review, we discuss the current status of this therapy in patients with mediastinal node-positive (N2)...

    journal_title:British journal of cancer

    pub_type: 杂志文章,评审

    doi:10.1038/sj.bjc.6603751

    authors: Kunitoh H,Suzuki K

    更新日期:2007-05-21 00:00:00

  • A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma.

    abstract::A chelating derivative of alpha-melanocyte stimulating hormone (MSH) has been synthesised, in which two molecules of the hormone are cross-linked by diethylenetriamine pentaacetic acid (DTPA). This compound, bisMSH-DTPA, was equipotent with MSH in an in vitro tyrosinase assay with Cloudman S91 melanoma cells. When DBA...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1990.409

    authors: Bard DR,Knight CG,Page-Thomas DP

    更新日期:1990-12-01 00:00:00

  • Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.

    abstract::Axillary lymph nodes draining mammary carcinoma showed an alteration of both micro-architectue and lymphocyte subpopulations. Lymph nodes with a normal or increased T and/or B lymphocyte compartment (assessed by histology) had a low incidence of nodal tumour spread, whilst hypocellularity of the T- or B-lymphocyte-dep...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.8

    authors: Eremin O,Roberts P,Plumb D,Stephens JP

    更新日期:1980-01-01 00:00:00

  • A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

    abstract::We investigated trends in first-time hospital admissions and deaths attributable to hepatocellular carcinoma (HCC) in a large population-based cohort of 22 073 individuals diagnosed with hepatitis C viral (HCV) infection through laboratory testing in Scotland in 1991-2006. We identified new cases of HCC through record...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604563

    authors: McDonald SA,Hutchinson SJ,Bird SM,Robertson C,Mills PR,Dillon JF,Goldberg DJ

    更新日期:2008-09-02 00:00:00

  • Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer.

    abstract:BACKGROUND:Rectal bleeding is a recognised early symptom of colorectal cancer. This study aimed to assess the diagnostic accuracy of symptoms, signs and diagnostic tests in patients with rectal bleeding in relation to risk of colorectal cancer in primary care. METHODS:Diagnostic accuracy systematic review. Medline (19...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1038/sj.bjc.6605426

    authors: Olde Bekkink M,McCowan C,Falk GA,Teljeur C,Van de Laar FA,Fahey T

    更新日期:2010-01-05 00:00:00

  • Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).

    abstract::A cytogenetic study was performed in 27 patients suspected of t-MDS or t-ANLL. In 12 patients the diagnosis of t-MDS or t-ANLL was confirmed by morphological, cytochemical and immunophenotypical analysis. The cases were classified as RA (one), RAEB (four), CMML (two), ANLL (five). They had received chemotherapy and/or...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1990.93

    authors: Sozzi G,Miozzo M,Orazi A,Calderone C,Castellano M,Viviani S,Santoro A,Pierotti MA,Della Porta G

    更新日期:1990-03-01 00:00:00

  • Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation-positive melanoma.

    abstract:BACKGROUND:In the coBRIM study, cobimetinib plus vemurafenib (C+V) significantly improved survival outcomes vs placebo and vemurafenib (P+V) in patients with advanced/metastatic BRAFV600-mutated melanoma. An analysis of health-related quality of life (HRQOL) from coBRIM is reported. METHODS:Patients completing the Eur...

    journal_title:British journal of cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1038/bjc.2017.488

    authors: Dréno B,Ascierto PA,Atkinson V,Liszkay G,Maio M,Mandalà M,Demidov L,Stroyakovskiy D,Thomas L,de la Cruz-Merino L,Dutriaux C,Garbe C,Bartley K,Karagiannis T,Chang I,Rooney I,Koralek DO,Larkin J,McArthur GA,Ribas A

    更新日期:2018-03-20 00:00:00

  • Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.

    abstract::Monoclonal antibodies to epithelial-cell antigenic determinants, labelled with 123I and 125I, were administered parenterally to immunodeficient mice bearing human tumours derived from a human cancer cell line. Anterior, posterior and lateral radioscans of the body were taken with a gamma scintillation camera at variou...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1982.157

    authors: Epenetos AA,Nimmon CC,Arklie J,Elliott AT,Hawkins LA,Knowles RW,Britton KE,Bodmer WF

    更新日期:1982-07-01 00:00:00

  • The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation.

    abstract:BACKGROUND:We previously reported that chaetocin has potent and selective anti-myeloma activity attributable to reactive oxygen species (ROS) induction imposed by inhibition of the redox enzyme thioredoxin reductase; we now detail its effects in solid tumours. METHODS:Cellular assays, transcriptional profiling and the...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.522

    authors: Isham CR,Tibodeau JD,Bossou AR,Merchan JR,Bible KC

    更新日期:2012-01-17 00:00:00

  • Mechanisms of adverse effects of anti-VEGF therapy for cancer.

    abstract::Advances in understanding the role of vascular endothelial growth factor (VEGF) in normal physiology are giving insight into the basis of adverse effects attributed to the use of VEGF inhibitors in clinical oncology. These effects are typically downstream consequences of suppression of cellular signalling pathways imp...

    journal_title:British journal of cancer

    pub_type: 杂志文章,评审

    doi:10.1038/sj.bjc.6603813

    authors: Kamba T,McDonald DM

    更新日期:2007-06-18 00:00:00